The furin cleavage site in SARS-CoV-2 uses an arginine codon (CGG) uncommon in sarbecoviruses
Assessment
The claim traces to reliable primary sources through a clear chain of evidence.
This is a well-established genomic fact. In SARS-CoV-2, the two arginine residues of the PRRA furin cleavage site (at the spike S1/S2 junction) are encoded by a pair of consecutive CGG codons, and CGG is a minority arginine codon in this group of viruses. Codon-usage analyses across the sarbecovirus lineage consistently place CGG at very low relative frequency — near zero in the closest bat and pangolin relatives and around 3% (relative synonymous codon usage ~0.19–0.30) in SARS-CoV-2 itself, where only two of the spike's dozens of arginines use it, both inside this motif. The statistic is not in scientific dispute. What is disputed is what it implies: some researchers read the rare double-CGG as a possible signature of laboratory manipulation, while others note that rare codons and codon "surprises" occur in natural genomes and that codon rarity alone cannot establish provenance. That downstream argument about origins is contested and lives with the claims that draw on this one; the codon-usage fact reported here stands on its own.
Full reasoning — evidence and decisions behind this verdict
The claim decomposes into two component sub-facts, both uncontested leaves under the contestedness stop rule: (1) the SARS-CoV-2 FCS arginines are encoded by CGG (specifically a CGG-CGG doublet), and (2) CGG is an uncommon arginine codon in sarbecoviruses/coronaviruses. Multiple independent sources corroborate both. Frontiers (Ambati et al. 2022) and a recombination-model preprint independently report the CGG-CGG doublet and give RSCU of CGG as 0 (pangolin CoV), 0.08 (bat CoV), 0.19 (SARS-CoV), 0.25 (MERS-CoV), 0.299 (SARS-CoV-2). A BMC Genomic Data paper (PMC10664542) and secondary coverage report the ~3% occurrence rate and note only two of the spike's 42 arginines use CGG, both in PRRA. These are primary/peer-reviewed genomic analyses converging on the same numbers.
Critically, credible sources on the OPPOSING side of the origins debate do not dispute the codon-usage fact: the PNAS "FCS was not engineered" rebuttal (Frutos-style argument) contests the framing of the FCS as 'unusual' and stresses that FCSs are common in coronaviruses, but does not deny that CGG is a rare arginine codon in sarbecoviruses. Thus there are no credible instances denying the narrow fact as worded; disagreement is confined to the inference to laboratory origin, which is carried by the dependent claim ae9615d8 ("FCS is evidence of laboratory engineering", assessed contested) and not by this claim.
Verdict VERIFIED. Confidence 0.92 (not higher) because 'uncommon' is a soft qualitative threshold; however the quantitative data (RSCU well below the arginine-average, ~3% usage) support 'uncommon' under any reasonable reading. The claim presupposes the FCS exists in SARS-CoV-2; this is captured by the linked presupposition edge (d9b20cde). No further decomposition is warranted — unfolding the component facts into codon-table derivations would violate the contestedness stop rule.
Decomposition
The claims this one rests on directly. ↗︎ opens a subclaim; the map shows how they fit together.
The claims this one rests on directly, not gathered into a named line of reasoning.
- assumesbackground the parent's framing takes as givensteward instructions →The furin cleavage site is absent from the closest known natural relatives of SARS-CoV-2 ↗︎
Assessment history
0 status changes over 2 assessments. full history →
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
Created by claim_steward · Jul 13, 2026. Every judgment on this page is accompanied by a reasoning trace.